Synapse

← Future Lipidology

Papers in Future Lipidology

Page 1 · newest first

  1. Sphingosine-1-phosphate synthesis and functions in mast cellsFuture Lipidology · 2008
  2. Oxidized LDL and the metabolic syndromeFuture Lipidology · 2008
  3. Augmentation Of The Renin–Angiotensin System By Hyper Cholesterolemia Promotes Vascular DiseasesFuture Lipidology · 2008
  4. Biology of LOX-1 in relation to atherogenesisFuture Lipidology · 2008
  5. Role of the ABC transporters ABCA1 and ABCG1 in foam cell formation and atherosclerosisFuture Lipidology · 2008
  6. Uncontrolled airway infl ammation in lung disease represents a defect in counter-regulatory signalingFuture Lipidology · 2008
  7. Insulin resistance and lipid disordersFuture Lipidology · 2008
  8. Therapeutic potential of phosphoethanolamine-bound C-reactive protein in atherosclerosisFuture Lipidology · 2008
  9. Risk of metabolic and vascular disease in South Asians: potential mechanisms for increased insulin resistanceFuture Lipidology · 2008
  10. Role of lipoprotein lipase in triglyceride metabolism: potential therapeutic targetFuture Lipidology · 2008
  11. Apolipoprotein AV: gene expression,physiological role in lipid metabolism and clinical relevanceFuture Lipidology · 2008
  12. Structure and function of the enigmatic Sec14 domain-containing proteins and theetiology of human diseaseFuture Lipidology · 2008
  13. Roles of eicosanoids in prostate cancerFuture Lipidology · 2008
  14. Ganglioside complexes as target antigens in Guillain–Barré syndrome and related disordersFuture Lipidology · 2008
  15. In vivo versus cell culture models: the example of lipid biosynthesis in the enterocyteFuture Lipidology · 2008
  16. The ins and outs of endocannabinoid signaling in healthy and diseased brainFuture Lipidology · 2008
  17. Ceramide signaling in cancer and stem cellsFuture Lipidology · 2008
  18. Evaluation of phospholipid transfer protein as a therapeutic targetFuture Lipidology · 2008
  19. Phytosterols in cardiovascular disease:innocuous dietary components,or accelerators of atherosclerosis?Future Lipidology · 2008
  20. Compartmentalizing oxidative stressFuture Lipidology · 2008
  21. Potential roles for inhibitors of arachidonic acid metabolism in prevention and treatment of breast cancerFuture Lipidology · 2008
  22. Myriocin as an atherosclerosis inhibitorFuture Lipidology · 2008
  23. Regulation of cellular steroid levels with special focus on oxysterol and estrogen metabolismFuture Lipidology · 2008
  24. Role of stearoyl-CoA desaturase in human metabolic diseaseFuture Lipidology · 2008
  25. GPIHBP1: a new chylomicronemia geneFuture Lipidology · 2008
  26. Current and future treatments of HIV-associated dyslipidemiaFuture Lipidology · 2008
  27. Prevalence of obesity amongst Chinese populations revisitedFuture Lipidology · 2008
  28. Lipase maturation factor l (Lmf1), a new gene in hypertriglyceridemiaFuture Lipidology · 2008
  29. Can we prevent Parkinson’s disease with n-3 polyunsaturated fatty acids?Future Lipidology · 2008
  30. Genetic basis of the lipid storage disordersFuture Lipidology · 2008
  31. Therapeutic potential of antiangiogenic agents for prevention and treatment of obesityFuture Lipidology · 2008
  32. Apolipoprotein E and anxietyFuture Lipidology · 2008
  33. Macronutrients and obesity: views, news and reviewsFuture Lipidology · 2008
  34. Use of extended-release niacin in clinical practiceFuture Lipidology · 2008
  35. Link between small-vessel vasculitides and atherosclerosisFuture Lipidology · 2008
  36. Systems-biology approach to sphingolipid-storage disordersFuture Lipidology · 2008
  37. Cholesterol metabolism and noncholesterol sterol distribution in lipoproteins of Type 1 diabetesFuture Lipidology · 2008
  38. Role of PPAR-γ2 polymorphisms in bodyweight regulationFuture Lipidology · 2008
  39. Effect of exercise on lipolysis in adipose tissueFuture Lipidology · 2008
  40. Macrophage infiltration into adipose tissue: initiation, propagation and remodelingFuture Lipidology · 2008
  41. Postprandial triglyceride-rich lipoproteins in insulin resistance and Type 2 diabetesFuture Lipidology · 2008
  42. Apolipoprotein M: structure and functionFuture Lipidology · 2008
  43. Apolipoprotein E and cholesterol in aging and disease in the brainFuture Lipidology · 2008
  44. Intestinal postprandial chylomicrons: state of the union between liver, gut and dyslipidemia?Future Lipidology · 2008
  45. DHCR7 mutations causing the Smith—Lemli—Opitz syndromeFuture Lipidology · 2008
  46. Long-term effects of trans fatty acid intake during pregnancy and lactation: does it have deleterious consequences?Future Lipidology · 2008
  47. Nutritional management of lipids for overweight and obesity: what can we achieve?Future Lipidology · 2008
  48. Role Of Adaptive Thermogenesis In Unsuccessful Weight-Loss InterventionFuture Lipidology · 2007
  49. Genetics of familial hypobetalipoproteinemiaFuture Lipidology · 2007
  50. Contribution Of Sphingolipids To The Pathogenesis Of ObesityFuture Lipidology · 2007